Clinical Trial Update: A Phase Ib/Ⅱ Clinical Trial of LBL-024 Combined With Paclitaxel in Patients With Platinum-resistant Ovarian Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase Ib/II study evaluating LBL-024 in combination with paclitaxel for platinum-resistant ovarian cancer, currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• LBL-024
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Nanjing Leads Biolabs Co.,Ltd | Conditions: Ovarian Cancer | Phase 1, Phase 2 | Status: RECRUITING